266 related articles for article (PubMed ID: 16140942)
1. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
5. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
7. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
[TBL] [Abstract][Full Text] [Related]
9. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
11. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
13. Spreading of methylation within RUNX3 CpG island in gastric cancer.
Homma N; Tamura G; Honda T; Matsumoto Y; Nishizuka S; Kawata S; Motoyama T
Cancer Sci; 2006 Jan; 97(1):51-6. PubMed ID: 16367921
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
15. [Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer].
Wu BW; Zhang J; Fei XF; Zhu ZG; Cao WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):165-8. PubMed ID: 17380460
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
[TBL] [Abstract][Full Text] [Related]
17. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
19. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
20. In vitro differentiation of Runx3-/- p53-/- gastric epithelial cells into intestinal type cells.
Fukamachi H; Mimata A; Tanaka I; Ito K; Ito Y; Yuasa Y
Cancer Sci; 2008 Apr; 99(4):671-6. PubMed ID: 18377419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
